Back to Results
First PageMeta Content
Benzoates / Dendrimer / Supramolecular chemistry / Docetaxel / Microbicides for sexually transmitted diseases / Paclitaxel / Prostate cancer / Chemotherapy / Chemistry / Medicine / Alkaloids


Starpharma’s docetaxel demonstrates targeted tumour delivery Melbourne, Australia; 29th October 2012: Starpharma Holdings Ltd (ASX:SPL;OTCQX: SPHRY) today reported significant tumour-targeting results with its propriet
Add to Reading List

Document Date: 2012-10-28 19:02:03

Open Document

File Size: 365,51 KB

Share Result on Facebook

City

Melbourne / /

Company

Melbourne Australia / Nufarm / Sanofi Aventis / Ansell Limited / 3 Starpharma Holdings Limited / AstraZeneca / Okamoto Industries Inc / Tokyo Stock Exchange / Starpharma Holdings Ltd / /

Country

Japan / Australia / /

Currency

USD / /

/

Event

Business Partnership / Earnings Announcement / /

Facility

Monash Institute of Pharmaceutical Science / /

IndustryTerm

dendrimer technology / delivery technology / docetaxel product / dendrimer products / pharmaceutical uses / /

MarketIndex

ASX 300 / /

MedicalCondition

cancer / HIV / genital herpes / bacterial vaginosis / tumour / sexually transmitted infections / specific cancer / metastases / breast cancer / tumours / /

MedicalTreatment

dendrimer / chemotherapy / dendrimers / /

Organization

Monash Institute of Pharmaceutical Science / FDA / /

Person

Jackie Fairley / Rebecca Wilson Mob / Ben Rogers / /

/

Position

general public pricing pressures / Company Secretary / Chief Executive Officer / market leader / leader in the development / /

Product

paclitaxel / Taxotere / /

Technology

drug delivery / dendrimer technology / antibodies / chemotherapy / delivery technology / /

URL

www.starpharma.com / /

SocialTag